Successful treatment of ventricular fibrillation storm triggered by short-long-short sequence; time to avoid managed

Hilmi Alnsasra1, Yuval Konstantino1, Sergiy Bereza1

  • 1Department of Cardiology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

Sudden cardiac death in hypertrophic cardiomyopathy (HCM) can be prevented with implantable cardioverter defibrillators (ICDs). Reprogramming ICDs from managed ventricular pacing (MVP) to DDD mode with ventricular rate stabilization (VRS) effectively suppressed life-threatening ventricular fibrillation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) is primarily due to ventricular tachyarrhythmias.
  • Implantable cardioverter defibrillator (ICD) therapy is a key treatment for preventing SCD in high-risk patients.
  • Managed Ventricular Pacing (MVP) mode is designed to minimize ventricular pacing, but its interaction with arrhythmia prevention algorithms requires careful consideration.

Observation:

  • A 28-year-old male with HCM and an ICD (programmed in MVP mode) experienced recurrent ventricular fibrillation (VF) and ICD shocks despite antiarrhythmic drugs.
  • Analysis of stored electrograms revealed that VF was consistently initiated by short-long-short sequences.
  • The Ventricular Rate Stabilization (VRS) algorithm, when activated within the MVP mode, failed to prevent these recurrent VF episodes.

Findings:

  • Deactivating the MVP mode and reprogramming the ICD to DDD mode with the VRS algorithm enabled resulted in complete arrhythmia suppression.
  • This reprogramming successfully prevented further episodes of VF and avoided ICD shocks.
  • The study highlights that the VRS algorithm's effectiveness in preventing short-long-short sequence-induced ventricular arrhythmias is compromised when the ICD is in AAI mode during MVP.

Implications:

  • Physicians managing HCM patients with ICDs must be aware of the limitations of the VRS algorithm within the MVP mode.
  • Reprogramming ICDs to a different pacing mode (e.g., DDD) may be necessary to effectively utilize the VRS algorithm for preventing specific ventricular arrhythmias.
  • Optimizing ICD programming based on individual patient arrhythmia patterns, particularly short-long-short sequences, is crucial for effective SCD prevention in HCM.

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
709
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.3K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
926
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
465